Rapid and precise identification of putative bacterial pathogens is critically important in protecting U.S. agriculture. This project leverages genome sequencing and genome-based classification to precisely identify select agents and other high risk quarantine pathogens and conclusively distinguish them from non-pathogens and closely related pathogens already present in the United States. While the experimental work is focused on Ralstonia solanacearum (Rs), the employed genome sequence-based approach is expandable to other bacterial pathogens.
Valent BioSciences is a worldwide leader in the research, development and commercialization of biorational products for the agricultural, public health and forest health markets.
The Valent BioSciences portfolio includes bioinsecticides, biofungicides, bionematicides, mycorrhizal fungi, and plant growth regulators used in sustainable systems around the world.